Our results suggest that the impact of blood calcium on NAFLD may be altered by albumin, which requires that clinicians pay close attention to changes in serum calcium, as well as albumin, in people at risk for NAFLD. This evidence concerns the gene ALB and metabolic dysfunction-associated steatotic liver disease.